Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
After publication of our article [1] we were notified that Figure 1 was wrongly presented.
Main Authors: | Sanne Y. Smith-Apeldoorn, Jolien K. E. Veraart, Jeanine Kamphuis, Antoinette D. I. van Asselt, Daan J. Touw, Marije aan het Rot, Robert A. Schoevers |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | BMC Psychiatry |
Online Access: | https://doi.org/10.1186/s12888-019-2398-7 |
Similar Items
-
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
by: Sanne Y. Smith-Apeldoorn, et al.
Published: (2019-11-01) -
Esketamine in Treatment Resistant Depression: The Way to Remission
by: João Facucho-Oliveira, et al.
Published: (2021-03-01) -
A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression
by: Eduardo Jorge Muniz Magalhães, et al.
Published: (2021-08-01) -
Intrapersonal and interpersonal concomitants of facial blushing during everyday social encounters.
by: Marije aan het Rot, et al.
Published: (2015-01-01) -
The influence of affective empathy and autism spectrum traits on empathic accuracy.
by: Marije aan het Rot, et al.
Published: (2014-01-01)